220 related articles for article (PubMed ID: 38276081)
21. Immediate start of hormonal contraceptives for contraception.
Lopez LM; Newmann SJ; Grimes DA; Nanda K; Schulz KF
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD006260. PubMed ID: 23235628
[TBL] [Abstract][Full Text] [Related]
22. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2.
Visser J; Snel M; Van Vliet HA
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD003990. PubMed ID: 23543528
[TBL] [Abstract][Full Text] [Related]
23. Association of Hormonal Contraceptive Use With Adverse Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials and Cohort Studies.
Brabaharan S; Veettil SK; Kaiser JE; Raja Rao VR; Wattanayingcharoenchai R; Maharajan M; Insin P; Talungchit P; Anothaisintawee T; Thakkinstian A; Chaiyakunapruk N
JAMA Netw Open; 2022 Jan; 5(1):e2143730. PubMed ID: 35029663
[TBL] [Abstract][Full Text] [Related]
24. Comparative study on the efficacy, acceptability, and side effects of a contraceptive pill administered by the oral and the vaginal route: an international multicenter clinical trial.
Coutinho EM; Mascarenhas I; de Acosta OM; Flores JG; Gu ZP; Ladipo OA; Adekunle AO; Otolorin EO; Shaaban MM; Abul Oyoon M
Clin Pharmacol Ther; 1993 Nov; 54(5):540-5. PubMed ID: 8222497
[TBL] [Abstract][Full Text] [Related]
25. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2.
Visser J; Snel M; Van Vliet HA
Cochrane Database Syst Rev; 2006 Oct; (4):CD003990. PubMed ID: 17054193
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis.
López-Picado A; Lapuente O; Lete I
Eur J Contracept Reprod Health Care; 2017 Apr; 22(2):131-146. PubMed ID: 28256919
[TBL] [Abstract][Full Text] [Related]
27. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
Dragoman M; Curtis KM; Gaffield ME
Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
[TBL] [Abstract][Full Text] [Related]
28. 20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception.
Gallo MF; Nanda K; Grimes DA; Schulz KF
Cochrane Database Syst Rev; 2005 Apr; (2):CD003989. PubMed ID: 15846690
[TBL] [Abstract][Full Text] [Related]
29. Immediate start of hormonal contraceptives for contraception.
Lopez LM; Newmann SJ; Grimes DA; Nanda K; Schulz KF
Cochrane Database Syst Rev; 2008 Apr; (2):CD006260. PubMed ID: 18425943
[TBL] [Abstract][Full Text] [Related]
30. A review of transdermal hormonal contraception : focus on the ethinylestradiol/norelgestromin contraceptive patch.
Graziottin A
Treat Endocrinol; 2006; 5(6):359-65. PubMed ID: 17107221
[TBL] [Abstract][Full Text] [Related]
31. The effect of non-oral hormonal contraceptives on hypertension and blood pressure: A systematic review and meta-analysis.
Kalenga CZ; Dumanski SM; Metcalfe A; Robert M; Nerenberg KA; MacRae JM; Premji Z; Ahmed SB
Physiol Rep; 2022 May; 10(9):e15267. PubMed ID: 35510324
[TBL] [Abstract][Full Text] [Related]
32. Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.
Lauring JR; Lehman EB; Deimling TA; Legro RS; Chuang CH
Am J Obstet Gynecol; 2016 Sep; 215(3):330.e1-7. PubMed ID: 27059507
[TBL] [Abstract][Full Text] [Related]
33. Combination contraceptives: effects on weight.
Gallo MF; Lopez LM; Grimes DA; Carayon F; Schulz KF; Helmerhorst FM
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003987. PubMed ID: 24477630
[TBL] [Abstract][Full Text] [Related]
34. Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease.
Ker K; Tansley G; Beecher D; Perner A; Shakur H; Harris T; Roberts I
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD011386. PubMed ID: 25914907
[TBL] [Abstract][Full Text] [Related]
35. Immediate versus delayed postpartum insertion of contraceptive implant for contraception.
Sothornwit J; Werawatakul Y; Kaewrudee S; Lumbiganon P; Laopaiboon M
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011913. PubMed ID: 28432791
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
Pollok J; van Agteren JE; Carson-Chahhoud KV
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
[TBL] [Abstract][Full Text] [Related]
37. Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.
Naheed B; Kuiper JH; Uthman OA; O'Mahony F; O'Brien PM
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010503. PubMed ID: 28257559
[TBL] [Abstract][Full Text] [Related]
38. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.
Fraison E; Kostova E; Moran LJ; Bilal S; Ee CC; Venetis C; Costello MF
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD005552. PubMed ID: 32794179
[TBL] [Abstract][Full Text] [Related]
39. Pill, patch or ring? A mixed methods analysis of provider counseling about combined hormonal contraception.
Craig AD; Steinauer J; Kuppermann M; Schmittdiel JA; Dehlendorf C
Contraception; 2019 Feb; 99(2):104-110. PubMed ID: 30227121
[TBL] [Abstract][Full Text] [Related]
40. No-daily hormonal contraception today: general overview and application in specific clinical settings.
Bounous VE; Actis S; Rosso R; Giorgi M; Tiranini L; Nappi RE; Biglia N
Gynecol Endocrinol; 2023 May; 39(1):2214626. PubMed ID: 37199597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
